211 related articles for article (PubMed ID: 24534492)
1. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
[TBL] [Abstract][Full Text] [Related]
2. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
3. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
[TBL] [Abstract][Full Text] [Related]
4. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
5. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
6. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
[TBL] [Abstract][Full Text] [Related]
7. Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
Sato T; Iwase M; Miyama M; Komai M; Ohshima E; Asai A; Yano H; Miki I
Pharmacology; 2013; 91(5-6):305-13. PubMed ID: 23751403
[TBL] [Abstract][Full Text] [Related]
8. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.
Nakagami Y; Kawashima K; Yonekubo K; Etori M; Jojima T; Miyazaki S; Sawamura R; Hirahara K; Nara F; Yamashita M
Eur J Pharmacol; 2009 Dec; 624(1-3):38-44. PubMed ID: 19818758
[TBL] [Abstract][Full Text] [Related]
9. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
[TBL] [Abstract][Full Text] [Related]
10. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4).
Wang Y; Zhang Y; Yang X; Han W; Liu Y; Xu Q; Zhao R; Di C; Song Q; Ma D
Life Sci; 2006 Jan; 78(6):614-21. PubMed ID: 16137713
[TBL] [Abstract][Full Text] [Related]
11. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
12. A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.
Anderson CA; Patel P; Viney JM; Phillips RM; Solari R; Pease JE
J Leukoc Biol; 2020 Mar; 107(3):455-466. PubMed ID: 32052476
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.
Imai T; Chantry D; Raport CJ; Wood CL; Nishimura M; Godiska R; Yoshie O; Gray PW
J Biol Chem; 1998 Jan; 273(3):1764-8. PubMed ID: 9430724
[TBL] [Abstract][Full Text] [Related]
14. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
17. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
[TBL] [Abstract][Full Text] [Related]
18. Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4.
Slack RJ; Hall DA
Br J Pharmacol; 2012 Jul; 166(6):1774-92. PubMed ID: 22335621
[TBL] [Abstract][Full Text] [Related]
19. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
Juremalm M; Olsson N; Nilsson G
Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
[TBL] [Abstract][Full Text] [Related]
20. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]